Kanadevia Corporation TSE:7004

Report of Consolidated Financial Results For the Nine Months Ended December 31, 2025[PDF:381.8 KB]

Published

Source: MarketScreener

Report of Consolidated Financial Results

For the Nine Months Ended December 31, 2025

Name of Company: Kanadevia Corporation

February 5, 2026

Code Number:

Stock Exchange Listing:

7004 URL: https://www.kanadevia.com/ Tokyo

Representative: Michi Kuwahara, President & Chief Executive Officer

Contact Person: Shunji Kimura, Executive Officer, General Manager of Accounting Department

tel. +81-6-6569-0022

This "Consolidated Financial Results" has been prepared in accordance with accounting principles generally accepted in Japan.

(Figures are rounded down to the nearest million yen.)

  1. Business results and financial position for the nine months ended December 31, 2025 (April 1 - December 31, 2025)

    1. Results of operations (Accumulated)

      (Percentages show rates of increase or decrease from the period a year earlier.)

      Net sales

      (million yen) (%)

      Operating income

      (million yen) (%)

      Ordinary income

      (million yen) (%)

      Profit attributable to

      shareholders of Kanadevia (million yen) (%)

      9 months ended Dec. 31, 2025

      424,740

      2.7

      (4,666)

      -

      (4,963)

      -

      (6,311)

      -

      9 months ended Dec. 31, 2024

      413,432

      11.0

      9,746

      2.5

      5,917

      (35.3)

      5,393

      (9.5)

      Net income per share

      (yen)

      Net income per share-diluted

      (yen)

      9 months ended Dec. 31, 2025

      (37.52)

      -

      9 months ended Dec. 31, 2024

      32.04

      -

    2. Financial position

    Total assets

    (million yen)

    Net assets

    (million yen)

    Shareholders' equity to total assets

    (%)

    As of December 31, 2025

    655,217

    186,893

    27.0



    As of March 31, 2025

    609,666

    197,895

    31.1

    (Reference) Shareholders' equity: Yen 176,653 million (December 31, 2025), Yen 189,364 million (March 31, 2025)

  2. Dividends

    Record Date

    Dividends per share (yen)

    Interim

    Year-end

    Annual

    Year ended March 31, 2025

    0.0

    25.0

    25.0

    Year ending March 31, 2026

    0.0

    Year ending March 31, 2026 (Forecast)

    25.0

    25.0

    (Note) Revisions to the dividends forecast most recently announced：None

  3. Forecast of consolidated earnings for the fiscal year ending March 31, 2026 (April 1, 2025 - March 31, 2026)

    (Percentages show rates of increase or decrease from the period a year earlier.)

    Net sales

    (million yen) (%)

    Operating income

    (million yen) (%)

    Ordinary income

    (million yen) (%)

    Profit attributable to shareholders of Kanadevia

    (million yen) (%)

    Net income per share - basic (yen)

    Year ending March 31, 2026

    620,000

    1.6

    13,500

    (49.9)

    13,000

    (46.6)

    5,000

    (77.4)

    29.73

    (Note) Revisions to the forecast of consolidated earnings most recently announced：Yes

  4. Notes

    1. Significant changes in the scope of consolidation during the period: Yes

      Excluded: H&F Corporation, H&F SERVICES U.S.A., INC., H&F Services(Thailand) Co.,Ltd., H&F EUROPE LIMITED

    2. Specific accounting policies applied in the quarterly consolidated financial statements: Yes

    3. Changes in accounting policies, changes in accounting estimates and restatements

      1. Changes in accounting policies as per the revision of accounting standards: None

      2. Changes in accounting policies other than (i) above: None

      3. Changes in accounting estimates: None

      4. Restatements: None

    4. Number of shares issued and outstanding (common stock)

      1. Number of shares issued and outstanding (including treasury stock) December 31, 2025 170,214,843 shares

        March 31, 2025 170,214,843 shares

      2. Number of shares held in treasury

        December 31, 2025 1,970,878 shares

        March 31, 2025 2,026,463 shares

      3. Average number of shares during the respective periods

        Nine months ended December 31, 2025 168,229,116 shares

        Nine months ended December 31, 2024 168,336,574 shares

        (Note) The number of treasury stock at end of period includes the Company's shares held by the BIP (Board Incentive Plan) Trust established for the remuneration plan for the Company's directors, etc. (271,016 shares as of December 31, 2025, 329,630 shares as of March 31, 2025). The Company's shares held by the BIP Trust are included in the number of shares of treasury stock which are deducted from the number of shares when calculating the average number of shares outstanding during the period.

    5. Review for attached consolidated quarterly financial statements by certified public accountants or an audit firm: None

    6. Forward -looking statements are based on information currently available to Kanadevia Corporation. Therefore, those forward-looking statements include unknown risks and uncertainties. Accordingly, you should note that the actual results could differ materially from those forward-looking statements. Risks and uncertainties that could influence the ultimate outcome include, but are not limited, to the economic conditions surrounding Kanadevia Corporation.

  5. Consolidated Balance Sheets

Assets

(Millions of yen) As of March 31, 2025 As of December 31, 2025

Current assets

Cash and deposits 70,763 68,770

Notes and accounts receivable - trade, and

contract assets

228,020

232,075

Securities

1

1

Merchandise and finished goods

2,049

3,178

Work in process

8,261

18,850

Raw materials and supplies

12,772

14,459

Other

36,135

46,749

Allowance for doubtful accounts

(889)

(1,467)

Total current assets

357,114

382,617

Non-current assets

Property, plant and equipment

Buildings and structures, net

41,034

31,079

Land

52,414

51,593

Other, net

42,612

58,616

Total property, plant and equipment

136,060

141,290

Intangible assets

Goodwill

14,060

15,482

Other

27,158

31,728

Total intangible assets

41,218

47,210

Investments and other assets

Other

75,947

84,856

Allowance for doubtful accounts

(694)

(767)

Total investments and other assets

75,252

84,089

Total non-current assets

252,532

272,589

Deferred assets

20

9

Total assets

609,666

655,217

As of March 31, 2025 As of December 31, 2025

Liabilities

Current liabilities

Notes and accounts payable - trade

56,913

42,128

Electronically recorded obligations - operating

8,910

7,766

Short-term borrowings

36,396

77,165

Current portion of bonds payable

10,000

10,000

Lease liabilities

1,661

1,552

Accrued expenses

81,803

81,846

Income taxes payable

4,966

3,299

Contract liabilities

40,600

82,804

Provision for share-based payments

52

47

Provision for expenses related to quality

misconduct

1,484

2,075

Provision for construction warranties

17,394

16,913

Provision for loss on construction contracts

7,063

7,903

Other

27,034

28,823

Total current liabilities

294,283

362,326

Non-current liabilities

Bonds payable

10,000

-

Long-term borrowings

70,132

68,275

Lease liabilities

7,574

7,797

Deferred tax liabilities

5,820

6,184

Retirement benefit liability

16,468

16,235

Provision for retirement benefits for directors

(and other officers)

29

25

Provision for loss on litigation

946

896

Provision for demolition and removal

858

1,073

Asset retirement obligations

1,125

1,128

Other

4,532

4,378

Total non-current liabilities

117,488

105,996

Total liabilities

411,771

468,323

Net assets

Shareholders' equity

Share capital

45,442

45,442

Capital surplus

7,802

7,802

Retained earnings

118,870

108,345

Treasury shares

(1,334)

(1,284)

Total shareholders' equity

170,780

160,305

Accumulated other comprehensive income

Valuation difference on available-for-sale

securities

1,476

2,208

Deferred gains or losses on hedges

528

1,488

Revaluation reserve for land

(20)

(20)

Foreign currency translation adjustment

2,794

1,029

Remeasurements of defined benefit plans

13,804

11,642

Total accumulated other comprehensive 18,583 16,347 income

Non-controlling interests

8,530

10,240

Total net assets

197,895

186,893

Total liabilities and net assets

609,666

655,217

Nine months ended December 31, 2024

Nine months ended December 31, 2025

Net sales

413,432

424,740

Cost of sales

341,393

355,805

Gross profit

72,038

68,935

Selling, general and administrative expenses

62,292

73,602

Operating profit (loss)

9,746

(4,666)

Non-operating income

Interest income

948

1,065

Dividend income

170

304

Share of profit of entities accounted for using

equity method

-

1,773

Foreign exchange gains

319

-

Other

936

1,934

Total non-operating income

2,374

5,077

Non-operating expenses

Interest expenses

829

1,037

Share of loss of entities accounted for using

equity method

407

-

Foreign exchange losses

-

2,904

Other

4,965

1,433

Total non-operating expenses

6,202

5,374

Ordinary profit (loss)

5,917

(4,963)

Extraordinary income

Settlement income

2,205

-

Reversal of provision for loss on business liquidation

729 －

Total extraordinary income 2,934 －

Extraordinary losses

Impairment losses

-

1,612

Expenses related to quality misconduct

-

1,401

Provision for decommissioning and removals

-

214

Total extraordinary losses

-

3,228

Profit (loss) before income taxes

8,852

(8,192)

Income taxes

3,330

(1,929)

Profit (loss)

5,522

(6,263)

Profit attributable to non-controlling interests

128

48

Profit (loss) attributable to owners of parent

5,393

(6,311)